Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-Philippe Lalonde is active.

Publication


Featured researches published by Jean-Philippe Lalonde.


The EMBO Journal | 1997

The membrane‐proximal intracytoplasmic tyrosine residue of HIV‐1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells

Robert Lodge; Jean-Philippe Lalonde; Guy Lemay; Éric A. Cohen

Budding of retroviruses from polarized epithelial Madin–Darby canine kidney cells (MDCK) takes place specifically at the basolateral membrane surface. This sorting event is suspected to require a specific signal harbored by the viral envelope glycoprotein and it was previously shown that, as for most basolateral proteins, the intracytoplasmic domain plays a crucial role in this targeting phenomenon. It is well known that tyrosine‐based motifs are a central element in basolateral targeting signals. In the present study, site‐directed mutagenesis was used to generate conservative or non‐conservative substitutions of each four intracytoplasmic tyrosines of the human immunodeficiency virus (HIV‐1) envelope glycoprotein. This approach revealed that the membrane‐proximal tyrosine is essential to ensure both the basolateral localization of envelope glycoprotein and the basolateral targeting of HIV‐1 virions. Substitutions of the membrane‐proximal tyrosine did not appear to affect incorporation of envelope glycoprotein into the virions, as assayed by virion infectivity and protein content, nor its capability to ensure its role in viral infection, as determined by viral multiplication kinetics. Altogether, these results indicate that the intracytoplasmic domain of the HIV‐1 envelope glycoprotein harbors a unique, tyrosine‐based, basolateral targeting signal. Such a tyrosine‐based targeting signal may play a fundamental role in HIV transmission and pathogenesis.


The EMBO Journal | 1999

HLS7, a hemopoietic lineage switch gene homologous to the leukemia‐inducing gene MLF1

James H. Williams; Louise N. Daly; Evan Ingley; Jennifer Beaumont; Peta A. Tilbrook; Jean-Philippe Lalonde; J.P. Stillitano; S. Peter Klinken

Hemopoietic lineage switching occurs when leukemic cells, apparently committed to one lineage, change and display the phenotype of another pathway. cDNA representational difference analysis was used to identify myeloid‐specific genes that may be associated with an erythroid to myeloid lineage switch involving the murine J2E erythroleukemic cell line. One of the genes isolated (HLS7) is homologous to the novel human oncogene myeloid leukemia factor 1 (MLF1) involved in the t(3;5)(q25.1;q34) translocation associated with acute myeloid leukemia. Enforced expression of HLS7 in J2E cells induced a monoblastoid phenotype, thereby recapitulating the spontaneous erythroid to myeloid lineage switch. HLS7 also inhibited erythropoietin‐ or chemically‐induced differentiation of erythroleukemic cell lines and suppressed development of erythropoietin‐responsive colonies in semi‐solid culture. However, intracellular signaling activated by erythropoietin was not impeded by ectopic expression of HLS7. In contrast, HLS7 promoted maturation of M1 monoblastoid cells and increased myeloid colony formation in vitro. These data show that HLS7 can influence erythroid/myeloid lineage switching and the development of normal hemopoietic cells.


Journal of Biological Chemistry | 2002

MADM, a Novel Adaptor Protein That Mediates Phosphorylation of the 14-3-3 Binding Site of Myeloid Leukemia Factor 1

Raelene Lim; Louise N. Winteringham; James H. Williams; Ross K. McCulloch; Evan Ingley; Jim Y. Tiao; Jean-Philippe Lalonde; Schickwann Tsai; Peta A. Tilbrook; Yi Sun; Xiaohua Wu; Stephan W. Morris; S. Peter Klinken

A yeast two-hybrid screen was conducted to identify binding partners of Mlf1, an oncoprotein recently identified in a translocation with nucleophosmin that causes acute myeloid leukemia. Two proteins isolated in this screen were 14-3-3ζ and a novel adaptor, Madm. Mlf1 contains a classic RSXSXP sequence for 14-3-3 binding and is associated with 14-3-3ζ via this phosphorylated motif. Madm co-immunoprecipitated with Mlf1 and co-localized in the cytoplasm. In addition, Madm recruited a serine kinase, which phosphorylated both Madm and Mlf1 including the RSXSXP motif. In contrast to wild-type Mlf1, the oncogenic fusion protein nucleophosmin (NPM)-MLF1 did not bind 14-3-3ζ, had altered Madm binding, and localized exclusively in the nucleus. Ectopic expression of Madm in M1 myeloid cells suppressed cytokine-induced differentiation unlike Mlf1, which promotes maturation. Because the Mlf1 binding region of Madm and its own dimerization domain overlapped, the levels of Madm and Mlf1 may affect complex formation and regulate differentiation. In summary, this study has identified two partner proteins of Mlf1 that may influence its subcellular localization and biological function.


Journal of Biological Chemistry | 2004

HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor

Jean-Philippe Lalonde; Raelene Lim; Evan Ingley; Peta A. Tilbrook; Martin Thompson; Ross K. McCulloch; Jennifer Beaumont; Carol Wicking; Helen J. Eyre; Grant R. Sutherland; Kathy Howe; Ellen Solomon; James H. Williams; S. Peter Klinken

Hemopoietic cells, apparently committed to one lineage, can be reprogrammed to display the phenotype of another lineage. The J2E erythroleukemic cell line has on rare occasions developed the features of monocytic cells. Subtractive hybridization was used in an attempt to identify genes that were up-regulated during this erythroid to myeloid transition. We report here on the isolation of hemopoietic lineage switch 5 (Hls5), a gene expressed by the monocytoid variant cells, but not the parental J2E cells. Hls5 is a novel member of the RBCC (Ring finger, B box, coiled-coil) family of genes, which includes Pml, Herf1, Tif-1α, and Rfp. Hls5 was expressed in a wide range of adult tissues; however, at different stages during embryogenesis, Hls5 was detected in the branchial arches, spinal cord, dorsal root ganglia, limb buds, and brain. The protein was present in cytoplasmic granules and punctate nuclear bodies. Isolation of the human cDNA and genomic DNA revealed that the gene was located on chromosome 8p21, a region implicated in numerous leukemias and solid tumors. Enforced expression of Hls5 in HeLa cells inhibited cell growth, clonogenicity, and tumorigenicity. It is conceivable that HLS5 is one of the tumor suppressor genes thought to reside at the 8p21 locus.


Dna Sequence | 1998

Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene: PEREC1.

Elizabeth Freitas; Wen Jie Zhang; Jean-Philippe Lalonde; Guan Tay; Silvana Gaudieri; Linda K. Ashworth; Roger L. Dawkins

Through the sequencing of a 42kb cosmid clone we describe a new gene, designated PEREC1, located approximately 1.5kb centromeric of the human apolipoprotein (APO) E-C2 cluster. The combination of dotplot analysis, predicted coding potential and interrogation of the Expressed Sequence Tag (EST) database determined the genomic organisation of PEREC1. Sequence alignment with multiple overlapping ESTs confirmed the predicted splice sites. The predicted cDNA and amino acid sequences of PEREC1 have extensive similarity to the Caenorhabditis elegans protein, C18E9.6. Conserved structural and functional motifs have been defined by combining nucleotide and amino acid analyses to identify third base degeneracy and therefore selection at the protein level. The Poliovirus Receptor Related Protein2 gene (PRR2), previously mapped to chromosome 19q13.2 by Fluorescent In-Situ Hybridisation, has also been located approximately 17kb centromeric of APO E.


Journal of Virology | 1999

Polarized Human Immunodeficiency Virus Budding in Lymphocytes Involves a Tyrosine-Based Signal and Favors Cell-to-Cell Viral Transmission

Julie Deschambeault; Jean-Philippe Lalonde; Guillermo Cervantes-Acosta; Robert Lodge; Éric A. Cohen; Guy Lemay


Blood | 2009

Hls5, a Novel Ubiquitin E3 Ligase, Modulates Levels of Sumoylated GATA-1.

Louise N. Winteringham; Raelene Endersby; Jennifer Beaumont; Jean-Philippe Lalonde; Merlin Crossley; Svend Peter Klinken


Blood | 2008

Hls5 regulated erythroid differentiation by modulating GATA-1 activity

Raelene Endersby; Ian J. Majewski; Louise N. Winteringham; Jennifer Beaumont; Amy Samuels; Robin M. Scaife; Esther Lim; Merlin Crossley; S. Peter Klinken; Jean-Philippe Lalonde


Archive | 2009

Tumor Suppressor Factor

Svend Peter Klinken; Jean-Philippe Lalonde; James Howard Williams


Archive | 2000

HLS-5 tumor suppressor factor

Svend Peter Klinken; Jean-Philippe Lalonde; James H. Williams

Collaboration


Dive into the Jean-Philippe Lalonde's collaboration.

Top Co-Authors

Avatar

S. Peter Klinken

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Jennifer Beaumont

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Robin M. Scaife

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Svend Peter Klinken

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Raelene Lim

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

James H. Williams

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Louise N. Winteringham

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Evan Ingley

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Peta A. Tilbrook

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Raelene Endersby

University of Western Australia

View shared research outputs
Researchain Logo
Decentralizing Knowledge